Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
9.15
-0.10 (-1.08%)
At close: Nov 4, 2025, 4:00 PM EST
9.00
-0.15 (-1.64%)
After-hours: Nov 4, 2025, 4:23 PM EST
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $149.36 million as of November 4, 2025. Its market cap has increased by 191.01% in one year.
Market Cap
149.36M
Enterprise Value
142.18M
1-Year Change
191.01%
Ranking
Category
Stock Price
$9.15
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $149.36M, a decrease of -52.16%. That is a compound annual growth rate of -26.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 151.00M | 174.73% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |